Accounting for dynamic nanomaterial behavior in toxicological study design

Engineered nanomaterials are known to undergo dynamic physicochemical changes after synthesis. During dispersion, environmental aging, and biological exposure, they can agglomerate, dissolve, undergo surface complexation, acquire biomolecular coatings, or form secondary phases, converting a nominal single-material exposure into a time-dependent mixture of particles, dissolved species, and interfacial states. Although nanomaterial transformation is well established, its consequences are not yet considered consistently in toxicological study design and interpretation. Here, I argue that future studies should focus on four practical decisions: defining the material state at exposure start, recording conditioning and exposure history where it may alter interpretation, targeting early transition measurements when transformations may change the dominant response driver or delivered dose, and selecting a mechanism-relevant dose metric. Minimum reporting is a cross-cutting requirement across all four decisions. This approach is applicable across material classes, including dissolving metal and metal oxide nanomaterials, environmentally aged silver nanoparticles, persistent carbonaceous nanomaterials, and emerging porous materials such as metal-organic frameworks, and shifts attention from the pristine material toward the material state actually presented to the biological or environmental test system.